GenVec Inc. Says Cancer Therapy Increases Survival; Shares Up

May 29 (Reuters) - Genvec Inc said its gene therapy product, TNFerade, increased survival of patients with esophageal cancer longer than comparable studies, sending its shares up 11 percent before the bell.